E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
about
Prostaglandin E 1 for maintaining ductal patency in neonates with ductus-dependent cardiac lesionsDecision-Making for Surgery in the Management of Patients with Univentricular HeartPulmonary arterial structure in pulmonary atresia after prostaglandin E2 administrationProstaglandin E1: first stage palliation in neonates with congenital cardiac defects.Operative balloon dilatation for pulmonary atresia with intact ventricular septumEvaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.Pharmacological manipulation of the ductus arteriosus.Tetralogy of Fallot. The first 300 yearsIntermittent disappearance of a patent ductus arteriosus murmur: report of a case and review of the literature.Aging-shifted prostaglandin profile in endothelium as a factor in cardiovascular disordersThe significance of ventriculo-coronary arterial connections in the setting of pulmonary atresia with an intact ventricular septum.Surgical management of congenital heart defects: current trends.Persistent ductus arteriosus: most probably a primary congenital malformation.Management of the pediatric patient after cardiac surgeryLong-Term Survival of Individuals Born With Congenital Heart Disease: A Systematic Review and Meta-AnalysisProstaglandin E2 after septostomy for simple transposition.Frontiers in pediatric cardiology-specialty grand challenge.Anesthetic considerations for neonates undergoing modified Blalock-Taussig shunt and variations.Mortality and Operative Management for Patients Undergoing Repair of Coarctation of the Aorta: A Retrospective Review of the Pediatric Cardiac Care Consortium.The safety of postnatal transport of newborns prenatally diagnosed with duct-dependent congenital heart disease.PROSTAGLANDINS IN CONGENITAL HEART DISEASE.Prostaglandin E1 in suspected ductus dependent cardiac malformation.Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta.Pulmonary heart disease: pathophysiology, diagnostic signs, and therapy.Do prostaglandins regulate external gill regression in anurans?Pharmacologic manipulation of the ductus arteriosus in the neonate: a physiologic basis and current state of the art.Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulationThe prostaglandin challenge. Test to unmask obstructed total anomalous pulmonary venous connections in asplenia syndrome.Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomaliesEffect of prostaglandin E1 on pulmonary circulation in pulmonary atresia. A quantitative morphometric study.Responses of the post-term arterial duct to oxygen, prostaglandin E2, and the nitric oxide donor, 3-morpholinosydnonimine, in lambs and their clinical implications.Survival, by Birth Weight and Gestational Age, in Individuals With Congenital Heart Disease: A Population-Based StudyResponsiveness of the ductus arteriosus to prostaglandin E1 assessed by combined cross sectional and pulsed Doppler echocardiographyIncidence of Fever and Positive Bacterial Cultures in Neonates Receiving Prostaglandin.Lactacidosis in the neonate is minimized by prenatal detection of congenital heart disease.Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants.Prolonged prostaglandin-E2-associated periosteal reaction and elevated C-reactive protein levels.The Edgar Mannheimer Memorial lecture. From Maude to Claude: the musings of an insomniac in the era of evidence-based medicine.Neonatal coarctation repair using extended end-to-end anastomosis
P2860
Q24187669-04D1732E-5961-4795-A2F6-910AE9A9C7F7Q26797274-B19FB271-37E9-4FC5-B51C-5D197D6BE1F0Q28367351-DB4F6F9B-E739-47EA-9A5B-55EB2D8E467DQ33894972-5DB0D1AC-0749-483F-A368-8E546A8A1F3BQ34118462-C052C17D-E44A-4077-B3D6-C9199637B27DQ35602578-CE66C6C7-58CA-4983-B3AD-5D7F3E40BD09Q35603256-79FFC8C2-867C-4566-8AF8-F0A272F3DD79Q35653987-FDD3E50E-A6CA-4EEC-9706-5E4AFC30CAEDQ35822794-EF9F8CBF-36AD-49E5-92CE-FC90EC7210BEQ35829890-BE221B06-A98D-45B5-AD85-C399268D0A2AQ36258138-E1B83368-4314-4A93-9B58-EA9DC026D6D5Q36720807-4A2F33AC-363E-4101-A690-3A2756B4D594Q36801255-CB3E46EA-19B9-4C57-8EC3-664FAC439065Q36988494-6934A55C-C47F-4A4B-934C-9DD05AD195D5Q37076054-FC0944CF-6E5B-4C48-8046-FDE8E8D6319EQ37350830-423AC946-1CBD-4B43-97AA-D21360DFFA82Q37387431-0CEB10C1-9428-47B8-93EC-21F172DF1132Q38163069-D288218A-54B3-4684-8A2A-089628A8B53DQ38548218-85E8E4F6-C2C2-486E-8873-B7BBDDD718CDQ38573062-AF2EAA84-64F2-4717-94F0-9226A4CC080CQ38894692-1F50C457-2833-48AB-B9A1-CDBD5A78D14EQ38951819-F32FB053-BF8E-4E70-9B70-0BEFF764973FQ39487580-AE110C2C-4694-4B47-86B8-9798985344D0Q39574634-FD868F28-F029-4A59-9781-33CB01E0FA07Q39578913-37222C13-85EE-4B75-B65E-4009228CE59EQ39645382-61F3148E-39B1-4794-8EEE-AE834C0990A5Q40254006-73B768B7-22FC-4645-9EC8-D748EAB8959EQ41308244-EFEB8AC0-5639-4BE4-BCA9-A774D450C3F0Q41312884-69B0892C-688E-4653-AF5A-96DF68096EFEQ41312920-B988AA8F-7989-4413-B209-490F136873D0Q41316750-05BB219B-66CA-4F18-AE68-DAD90D401C3BQ41334194-B043541D-4636-402B-88A9-046EFF77BE20Q41627165-9426A193-11CB-4AB6-AFAF-4C24DF44A610Q41818506-827FB0DB-B5C6-4038-8652-ADD4A99DBA75Q41928028-EEECB086-7646-4974-98FE-C8FF4CF55814Q44016472-DD4FAE57-CFDB-4AF3-B5F3-7D2A7C5601A1Q44916311-44431A84-C972-4ADC-96BB-8EF3395F08C9Q47355741-816C8539-AED6-4D70-9BED-E41CC6382E40Q48585349-6CFDD5E0-F93C-4192-8142-8E740F5B546FQ56993949-89D3582E-802B-4E13-A955-14D2B8458CFB
P2860
E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
E-type prostaglandins: a new e ...... ongenital heart malformations.
@en
E-type prostaglandins: a new e ...... ongenital heart malformations.
@nl
type
label
E-type prostaglandins: a new e ...... ongenital heart malformations.
@en
E-type prostaglandins: a new e ...... ongenital heart malformations.
@nl
prefLabel
E-type prostaglandins: a new e ...... ongenital heart malformations.
@en
E-type prostaglandins: a new e ...... ongenital heart malformations.
@nl
P2093
P356
P1433
P1476
E-type prostaglandins: a new e ...... ongenital heart malformations.
@en
P2093
P304
P356
10.1161/01.CIR.53.4.728
P407
P577
1976-04-01T00:00:00Z